Volta Medical Appoints Bill Hoffman as Executive Chairman

Volta Medical Appoints Bill Hoffman as Executive Chairman

Volta Medical has appointed Bill Hoffman as Executive Chairman of its Board of Directors, bringing his extensive experience in guiding startups to success.

Volta Medical has appointed Bill Hoffman as the Executive Chairman of its Board of Directors, announced in a press release. Hoffman, who previously served as CEO of Inari Medical, is recognized for leading the company to significant growth and its eventual acquisition by Stryker for $4.9 billion.

Volta Medical, a health technology company based in Marseille, France, focuses on developing AI solutions to assist electrophysiologists in cardiac ablation procedures. Hoffman's appointment comes as the company aims to expand global access to its AI-driven solutions, which have shown improved efficacy outcomes for atrial fibrillation patients.

In addition to Hoffman's appointment, Jerome Kalifa, MD, PhD, has been named Executive Vice Chairman while continuing his role as Chief Medical Officer. This leadership change follows the publication of the TAILORED-AF clinical trial in Nature Medicine, highlighting the effectiveness of Volta's AI-guided procedures.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.

Also, consider following us on social media:

Subscribe to Daily AI Brief

Daily report covering major AI developments and industry news, with both top stories and complete market updates

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more